Charalambos Gogos

10.6k total citations · 1 hit paper
159 papers, 4.7k citations indexed

About

Charalambos Gogos is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Charalambos Gogos has authored 159 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Epidemiology, 42 papers in Infectious Diseases and 25 papers in Hepatology. Recurrent topics in Charalambos Gogos's work include Liver Disease Diagnosis and Treatment (23 papers), Sepsis Diagnosis and Treatment (22 papers) and Hepatitis C virus research (13 papers). Charalambos Gogos is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Sepsis Diagnosis and Treatment (22 papers) and Hepatitis C virus research (13 papers). Charalambos Gogos collaborates with scholars based in Greece, United States and United Kingdom. Charalambos Gogos's co-authors include Harry P. Bassaris, Athanassios Skoutelis, F Kalfarentzos, Nancy Mead, K. Kokkinis, Karolina Akinosoglou, Stelios F. Assimakopoulos, Dimitrios Siagris, Markos Marangos and N. Zoumbos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Charalambos Gogos

155 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic Options

2000 668 citations Charalambos Gogos, Athanassios Skoutelis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charalambos Gogos Greece	35	1.7k	999	688	659	591	159	4.7k
Matthias Girndt Germany	46	1.6k 0.9×	969 1.0×	270 0.4×	686 1.0×	626 1.1×	195	7.0k
Bart Maes Belgium	53	1.1k 0.6×	2.7k 2.7×	595 0.9×	1.1k 1.7×	616 1.0×	215	8.9k
Stefan H. Jacobson Sweden	42	1.2k 0.7×	1.3k 1.3×	531 0.8×	934 1.4×	190 0.3×	214	7.1k
Neal S. LeLeiko United States	40	2.0k 1.2×	1.6k 1.6×	843 1.2×	383 0.6×	886 1.5×	163	6.7k
Peter Verhamme Belgium	53	1.8k 1.1×	2.3k 2.3×	604 0.9×	934 1.4×	936 1.6×	350	13.1k
Éric Lerebours France	46	2.8k 1.6×	2.8k 2.8×	905 1.3×	693 1.1×	227 0.4×	211	6.6k
María Esteve Spain	46	4.5k 2.6×	2.1k 2.1×	799 1.2×	297 0.5×	696 1.2×	244	7.6k
Wolfgang Kruis Germany	42	2.0k 1.1×	2.4k 2.4×	379 0.6×	319 0.5×	466 0.8×	208	7.1k
Marcello Candelli Italy	33	715 0.4×	1.8k 1.8×	454 0.7×	505 0.8×	561 0.9×	186	4.1k
Nicole M. Isbel Australia	41	606 0.4×	1.2k 1.2×	317 0.5×	718 1.1×	292 0.5×	215	5.8k

Countries citing papers authored by Charalambos Gogos

Since Specialization

Citations

This map shows the geographic impact of Charalambos Gogos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalambos Gogos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalambos Gogos more than expected).

Fields of papers citing papers by Charalambos Gogos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charalambos Gogos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalambos Gogos. The network helps show where Charalambos Gogos may publish in the future.

Co-authorship network of co-authors of Charalambos Gogos

This figure shows the co-authorship network connecting the top 25 collaborators of Charalambos Gogos. A scholar is included among the top collaborators of Charalambos Gogos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charalambos Gogos. Charalambos Gogos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soriano, Àlex, Matteo Bassetti, Charalambos Gogos, et al.. (2024). Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study. JAC-Antimicrobial Resistance. 6(3). dlae078–dlae078. 1 indexed citations

Schinas, Georgios, Οlga Tsachouridou, Konstantinos Protopapas, et al.. (2024). Testing Hepatitis E Seroprevalence among HIV-Infected Patients in Greece: The SHIP Study. Pathogens. 13(7). 536–536. 2 indexed citations

Gogos, Charalambos, et al.. (2024). Durability of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2. Vaccines. 12(12). 1444–1444. 2 indexed citations

Akinosoglou, Karolina, et al.. (2024). Amphotericin B in the Era of New Antifungals: Where Will It Stand?. Journal of Fungi. 10(4). 278–278. 10 indexed citations

Gogos, Charalambos, et al.. (2024). Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes. Viruses. 16(5). 685–685. 9 indexed citations

Akinosoglou, Karolina, et al.. (2023). COVID-19 Pharmacotherapy in Pregnancy: A Literature Review of Current Therapeutic Choices. Viruses. 15(3). 787–787. 9 indexed citations

Dimοpoulos, George, José Garnacho‐Montero, Elisabeth Paramythiotou, et al.. (2023). Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?. Diagnostics. 13(6). 1106–1106. 13 indexed citations

Akinosoglou, Karolina, Georgios Schinas, Georgia Kaiafa, et al.. (2023). Remdesivir Use in the Real-World Setting: An Overview of Available Evidence. Viruses. 15(5). 1167–1167. 8 indexed citations

Metallidis, Symeon, Οlga Tsachouridou, Maria Chini, et al.. (2022). An exploration of the quality of life of people living with HIV in Greece: Challenges and opportunities. PLoS ONE. 17(4). e0266962–e0266962. 4 indexed citations

10.

Petrakis, Vasileios, Vasiliki Rapti, Karolina Akinosoglou, et al.. (2022). Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia. Microorganisms. 10(10). 1949–1949. 4 indexed citations

11.

Triantos, Christos, Maria Kalafateli, Stelios F. Assimakopoulos, et al.. (2022). Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis. Frontiers in Medicine. 9. 836306–836306. 14 indexed citations

12.

Pavli, Androula, Kalliopi Papadima, Annita Vakali, et al.. (2020). A cluster of COVID-19 in pilgrims to Israel. Journal of Travel Medicine. 27(5). 15 indexed citations

13.

Karamouzos, Vasileios, Fotini Fligou, Charalambos Gogos, & Dimitrios Velissaris. (2020). High flow nasal cannula oxygen therapy in adults with COVID-19 respiratory failure. A case report. SHILAP Revista de lepidopterología. 90(2). 13 indexed citations

14.

Kyriazopoulou, Evdoxia, Dimitrios Velissaris, Maria‐Evangelia Adami, et al.. (2019). Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study. International Journal of Antimicrobial Agents. 55(1). 105836–105836. 11 indexed citations

15.

Akinosoglou, Karolina, et al.. (2018). How well does qSOFA correspond to underlying systemic inflammatory response?. Cytokine. 110. 288–290. 1 indexed citations

16.

Vourli, Georgia, Georgios K. Nikolopoulos, Athanasios Skoutelis, et al.. (2018). HIV cascade of care in Greece: Useful insights from additional stages. PLoS ONE. 13(11). e0207355–e0207355. 12 indexed citations

17.

Kalafateli, Maria, Georgia Vourli, Cristina Rigamonti, et al.. (2017). Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study. Digestive Diseases and Sciences. 62(5). 1363–1372. 3 indexed citations

18.

Manolakopoulos, Spilios, Giorgos Bakoyannis, George Papatheodoridis, et al.. (2014). Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.. Europe PMC (PubMed Central). 6 indexed citations

19.

Starakis, Ioannis, et al.. (2010). Comparison of community and hospital-acquired bacteremia in a Greek university hospital: One year experience. 1(1). 1–8. 3 indexed citations

20.

Mitsi, Georgia, et al.. (2005). Patterns of antibiotic use among adults and parents in the community: A questionnaire-based survey in a Greek urban population. International Journal of Antimicrobial Agents. 25(5). 439–443. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact